Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
dmlabuda yeah the fact you bought at .42 said it was going to .70 and as it was falling off a cliff you didn't recognize it.
The fact that you don't know what the OS is
The fact that you don't know what the AS is
The fact that you don't know what the Float is
The fact that you don't seem to think that dilution will hurt the price.
The fact that you don't see any of this as important or relevant. You said It's already factored into the pps. No, dilution is like rust it just keeps eating away at the pps.
rosg is at .28. It has to rally 50% just to get back to .42. A buy at .20 would have been a good play for a bounce. If you want to talk about severe, OK. Oct 11 Rosg was $1.37 on or around Nov 23 it was .20 intraday. That is a SEVERE drop in less than 6 weeks.The fact is ROSG has a major gap down on heavy heavy volume relative to the historic volume. If it doesn't close the gap it's going to come back down to the low and lower. Basically this is a dead cat bounce. If that SEVERE rate of decline continues ROSG could be sub penny in less than 6 months.
dmlabud where in my post is the word severe? See the point is you don't even know how much or when it will occur. But dilution will occur and the price will continue to trend lower. Yes there will be rallies but always to an ever decreasing ema. I've been trading for about 26 years. I've seen guys like you come and go. Your what I call a TA bullshzzer. You learn enough to annotate charts usually after the fact and apply your expertise but it tends to be wrong. The very fact that you are choosing to ignore something as detrimental as dilution is Alarming. You never mentioned it in any of your posts. And it was the first thing I saw when I looked at a chart without any dd. That comes with years of experience and 100k's of charts.
Answer one question
Where do you go to find out the amount of dilution over a given time period?
If you can't answer this question you have no business trading a diluted POS pennystock.
dmlabuda you were way wrong on when you bought at .42 and said it was going to .70 why would it be any different this time. Your statements about dilution are naive to put it politely. It clearly shows you have very little experience in trading stocks especially diluted POS penny stocks.
"Because the price has apparently already discounted any effect of dilution."
I think you have it backwards, the dilution discounted the price or worse yet there hasn't been any dilution yet and the smart money left before anymore dilution. What happens if tomorrow all the buys are met with unlimited shares? Think of it like swimming upstream against a current that keeps getting stronger. Problem is you don't know and won't know. What you do know is the dilution will continue right thru the next reverse split with no regard for you or any of the shareholders. The nice name for it is called turning debt into equity.
Do you even know how to tell what the dilution rate is?
Do you know what the OS, AS and float is? What was the OS last week or a month ago? If you don't know you shouldn't be playing with a diluted POS Penny stock? Your limited knowledge and more limited experience is enough to get you and anyone listening to your dribble, into trouble and lose money.
Does anyone know why ALIM hasn't run yet? Chart has been primed, mm's are ready. I give you a clue, read the following and see what the problem is? What is missing? Company has only 7 mil float, 38 mil cash, $1.25 as share, over 80% of shares are held by insiders and institution. and NO Dilution.
Wednesday, November 30, 2011
* Health Care's 5 Worst November Flops at Motley Fool (Wed, Nov 30)
Sunday, November 20, 2011
* Noteworthy Insider Buys And Sells Across Multiple Sectors Last Weekat Seeking Alpha (Sun, Nov 20)
Friday, November 18, 2011
* Risky Business: Late Stage vs Early Stage Biotechat Forbes (Fri, Nov 18)
Wednesday, November 16, 2011
* Volatile Nature of Biotechnology Industry Weighs on Amarin Corporation and Alimera SciencesMarketwire (Wed, Nov 16)
Tuesday, November 15, 2011
* ALIMERA SCIENCES INC FinancialsEDGAR Online Financials (Tue, Nov 15)
* Alimera, pSivida Strike Out On Eye Implant Drugat Seeking Alpha (Tue, Nov 15)
Monday, November 14, 2011
* Nasdaq stocks posting largest volume increasesAP (Mon, Nov 14)
* Nasdaq stocks posting largest volume increasesAP (Mon, Nov 14)
* Alimera, pSivida fall further after FDA rejectionAP (Mon, Nov 14)
* Alimera Sciences downgraded by Rodman & RenshawBriefing.com (Mon, Nov 14)
* 5 of Last Week's Biggest Losers at Motley Fool (Mon, Nov 14)
* ALIMERA SCIENCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Nov 14)
* ALIMERA SCIENCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Nov 14)
Saturday, November 12, 2011
* These 2 Biotechs Got Crushed at Motley Fool (Sat, Nov 12)
Friday, November 11, 2011
* Friday’s biggest gaining and declining stocks at MarketWatch (Fri, Nov 11)
* Molycorp, Alimera Sciences: Biggest Price Decliners (MCP, ALIM)at The Wall Street Journal (Fri, Nov 11)
* Alimera plunges as FDA asks for new Iluvien trialsAP (Fri, Nov 11)
* FDA rejects Alimera eye drug again, seeks more trialsat Reuters (Fri, Nov 11)
* Alimera Sciences Receives Complete Response Letter From FDA for ILUVIEN(R)GlobeNewswire (Fri, Nov 11)
Thursday, November 10, 2011
* Smart Money Stock Picks in Strong Cash Positions at Motley Fool (Thu, Nov 10)
Monday, November 7, 2011
* Nasdaq stocks posting largest percentage increasesAP (Mon, Nov 7)
* ALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Nov 7)
* ALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Nov 7)
* Alimera Sciences Iluvien should be approved, says Oppenheimer theflyonthewall.com (Mon, Nov 7)
GE shooting star today. Big neg divergence on Accumulation.
http://stockcharts.com/h-sc/ui?s=GE&p=D&b=5&g=0&id=p44562969252
dmlabuda how long have you been trading? Do you know anything about how dilution works. I posted to you a few post ago (by the way which have been removed) that a 3 second look at the chart told me ROSG nothing more than a Diluted POS pennystock. It has a very distinctive chart pattern you won't find in any book or table. I refer to it as the dilution shzz slide chart.
http://stockcharts.com/h-sc/ui?s=ROSG&p=D&b=5&g=0&id=p06186303256
Since then I looked at the pr's
Delisting coming Kiss of Death followed by dilutive financing
Rosetta Genomics Company Profile: Rosetta Genomics develops and commercializes new diagnostic tests based on microRNAs, which the company says play an important role in normal function and in various pathologies. Current Share Price: 55 cents (Feb. 28) Listing Violation: Bid price. The listing rule requires that a company maintains a minimum closing bid price of $1 per share for its common stock. Rosetta Genomics shares last closed above $1 on Dec. 22. The company was hit in December with a separate delisting warning related to market value, equity and net income. Received Nasdaq Notice: Feb. 7 Management's Expected Action: Rosetta Genomics has until Aug. 8 to regain compliance with the minimum bid price requirement. While the company did not offer any indication of what it may do to regain compliance with the rule, Rosetta Genomics did note that the Nasdaq provided the company with an extension of a deadline to meet the market value, equity and net income requirement. The company must achieve certain milestones toward regaining compliance by Feb. 28 and April 29.
------------------
Dilution Dilution and more dilution.
Rosetta Genomics Initiates Closing of Private Placement
PR NewswirePress Release: Rosetta Genomics, Ltd. – Wed, Oct 19, 2011 6:09 PM EDT
PHILADELPHIA and REHOVOT, Israel, Oct. 19, 2011 /PRNewswire/ -- Rosetta Genomics, Ltd. ("Rosetta") (NASDAQ:ROSG - News), a leading developer and provider of microRNA-based molecular diagnostics, today announced that it has initiated the closing of its previously announced private placement and expects to receive $1.5 million in gross proceeds. The Company expects to issue an aggregate of 2,025,001 ordinary shares at a price of $0.75 per share. Series A warrants to purchase up to an aggregate of 2,025,001 ordinary shares at an exercise price of $1.00 per share and Series B warrants to purchase up to an aggregate of 1,012,501 ordinary shares at an exercise price equal to the greater of $0.01 or NIS 0.04 per share. Three affiliated investors that had entered into the definitive purchase agreement to purchase an aggregate of 573,000 ordinary shares have notified the Company that they do not intend to deliver payment for the shares. The net proceeds to Rosetta from the private placement, after deducting placement agent fees and other offering expenses payable by Rosetta, are expected to be approximately $1.3 million.
You bought ROSG on Nov 21st when it was clearly breaking down. look at the neg divergence of the accum/dist. The MACD was sick. The price had been at .42 then the day before you bought it dropped to .40. The stock had very little volume. What it did have was sells that took it down everytime. The Oct private placement nice way of saying dilution coming and it did Nov 22, a million shares traded and to the price to .20 on a Monster gap down.
Problem with dilution is you don't know when or how much is coming at any given time. It screws with the best TA. What you do know or should is that about 99% of companies that go down the path ROSG is going down will go sub-penny and eventually r/s and POOF gone or remorph into some other shell.
ROSG looks to be having enough trouble closing the gap. If it can't do that then back to .20 and lower.
UVXY $17.36 Get your VIX Fix. http://stockcharts.com/h-sc/ui?s=UVXY&p=D&yr=0&mn=3&dy=0&id=p45408506345
SRTY $13.97 2 huge gap downs in 3 days big mover http://stockcharts.com/freecharts/gallery.html?srty
ALIM $1.32 Long Tail Down Bounce 2-4 bagger potential.
://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p53909596363
ALIM $1.32 Long Tail Down Bounce Play in motion
://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p53909596363
ALIM $1.32 Long Tail Down Bounce Play Very nice chart.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p53909596363
Eh So why didn't you make the call before the drop? Here's a couple others UVXY buy now or wait?
http://stockcharts.com/h-sc/ui?s=UVXY&p=D&b=5&g=0&id=p12356033376
SRTY same thing?
http://stockcharts.com/freecharts/gallery.html?srty
ALIM $1.31 +11% Big Money Runner chart and we got it at the bottom. Rally just getting started. Realistically ALIM could go back to $3-6. Float is tiny 7 mil 81% of the OS is owned by insiders and institutions from $7-12 level. They aren't going to sell this at cheapo levels. They are going to take the increase in volume and drive the stock back higher. Don't be surprised to see new buy coverage from some GURU's before long.
ALIM good looking chart and we got it at the bottom. Rally just getting started. Realistically ALIM could go back to $3-6. Float is tiny 7 mil 81% of the OS is owned by insiders and institutions from $7-12 level. They aren't going to sell this at cheapo levels. They are going to take the increase in volume and drive the stock back higher. Don't be surprised to see new buy coverage from some GURU's before long.
Great day for ALIM $1.31 +12% big volume increase lots of upside in this one. $3-$6 is not unreasonable target in the next 3-4 weeks only 7mil float. Company fat with cash 35 mil $1.25 per share.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=2&dy=0&id=p47395296722
ALIM only 7 mil float over 60% of shares held by insiders large % of institutional holders. 34 mil in cash. This thing had no volume then one FDA trial rejected and some shareholder(s) dumped on what looks like a market order a large blk of shares into a stock that was very thinly traded. The way that works is say a million shares hit the on a market order when the price is at $7 and there is only maybe 20-50k on the bid side.The order will sit there and the mm's will call around and ask if anyone will pick up the shares and at what price. Once they decide they execute the trade or trades in a series of quick blks and the price gaps down hard. ALIM was at $7 on Nov 11 it gapped down from $6.33 to $2.55 then quickly lower. Right now at $1.35 we got discounted shares. Most of the shares are held at much higher levels like $8-12 a share. It's only a matter of time before the buy recommendations come out and an update on EU and more FDA trials. ALIM could be a very solid multibagger in the making.
accum, MACD, good solid buying volume spike today. Everything pointing north.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p45996398419
ALIM $1.34 basing next leg up could easily go over $2.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p45996398419
ALIM $1.34+ 15% next leg up could easily go over $2.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p45996398419
ALIM $1.34 basing next leg up could easily go over $2.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p45996398419
ALIM $1.40 +.23 +20% this Gem is going back into the intraday gap at $2.55-$6.33 Nov11. Over 90% of the shares are owned by institutions! The company has 36mil cash and will get FDA approval on 2 remaining trials.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p16597926793
ALIM $1.40 +.23 +20% this is going back into the intraday gap at $2.55-$6.33 Nov11. Over 90% of the shares are owned by institutions! The company has 36mil cash and will get FDA approval on 2 remaining trials.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p16597926793
ALIM $1.33 holy Crap $1.40x$1.42 .23 +20%
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p41724022448
ALIM $1.20 chart big bounce coming
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=4&dy=0&id=p93502830432
ALIM chart looks great! Great bounce potential with only 7 mil float. MACD turning north. price up Fri we may have seen all the selling. Any volume and this could 2-4 bag easily. I wouldn't be surprised to see buy coverage on it soon.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p79673497431
jstops ALIM chart looks great! Great bounce potential with only 7 mil float. MACD turning north. price up Fri we may have seen all the selling. Any volume and this could 2-4 bag easily. I wouldn't be surprised to see buy coverage on it soon.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=3&dy=0&id=p79673497431
ALIM $1.19 +1.71% this week was a good chance to accumulate. 2-3 bagger would not be surprising.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p57968933873
ALIM $1.19 for your Christmas shopping. News next week will drive huge bounce.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p92882354554
ALIM $1.19 7 mil float,intraday gap $6.33-$2.55 (Nov 11, $1.25 cash per share. Big bounce coming way oversold chart tells the story.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p92882354554
ALIM $1.19 7 mil float,intraday gap $6.33-$2.55 (Nov 11, $1.25 cash per share. Big bounce coming way oversold chart tells the story.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p92882354554
ALIM $1.19 7 mil float,intraday gap $6.33-$2.55 (Nov 11, $1.25 cash per share. Big bounce coming way oversold chart tells the story.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p92882354554
ALIM $1.2 7 mil Float $1.26 cash per share This is a MONSTER Bounce play in the making. Nov 11 FDA rejects 2nd trial but 2 remain. company has 36million in cash over 60% of shares are held by institutions. Stock was trading at $8 a share. It dropped on an intraday gap from $6.33 to $2.55 when someone did a market order into very light volume. Since then it has been caught in the market downdraft. Expect positive news sometime next week. The low volume from the holiday and the downward push of the market make for a great buying opp today. Intraday chart shows good size blks being bought up.
A move into the gap $2.55-$6.33 is coming soon.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=4&dy=0&id=p86405082568
ALIM $1.2 7 mil Float $1.26 cash per share This is a MONSTER Bounce play in the making. Nov 11 FDA rejects 2nd trial but 2 remain. company has 36million in cash over 60% of shares are held by institutions. Stock was trading at $8 a share. It dropped on an intraday gap from $6.33 to $2.55 when someone did a market order into very light volume. Since then it has been caught in the market downdraft. Expect positive news sometime next week. The low volume from the holiday and the downward push of the market make for a great buying opp today. Intraday chart shows good size blks being bought up.
A move into the gap $2.55-$6.33 is coming soon.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=4&dy=0&id=p86405082568
ALIM $1.2 7 mil Float $1.26 cash per share This is a MONSTER Bounce play in the making. Nov 11 FDA rejects 2nd trial but 2 remain. company has 36million in cash over 60% of shares are held by institutions. Stock was trading at $8 a share. It dropped on an intraday gap from $6.33 to $2.55 when someone did a market order into very light volume. Since then it has been caught in the market downdraft. Expect positive news sometime next week. The low volume from the holiday and the downward push of the market make for a great buying opp today. Intraday chart shows good size blks being bought up.
A move into the gap $2.55-$6.33 is coming soon.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&yr=0&mn=4&dy=0&id=p86405082568
ALIM$1.27 Don't wait for Black Friday to shop. from the initial Swacking, the bottoming yesterday, the basing and moving up today should continue toward $1.5. Look for Big breakout from $1.5 on news Monster intraday Gap from $2.55 -$6.33 (Nov 11) A 2-3 bagger on 10,000-30,000 shares could make for a good Christmas.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p10262703302
ALIM $1.26 only 7 mil float $1.25 cash per share. Intraday Gap from $6.33- $2.55. Nov 11 FDA rejected 2nd trial someone dump on a market order into a lightly trade stock and Bam down she went. Two more FDA trials remain company has 36million in cash. Chart set up is the best a bounce into the gap is coming very soon the stock is basing and moving higher today. Use this week to accumulate. Expect news updating shareholders next week. This could easily run back to $4-7 a share.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p78879038318
ALIM $1.26 ALERT! only 7 mil float $1.25 cash per share. Intraday Gap from $6.33- $2.55. Nov 11 FDA rejected 2nd trial someone dump on a market order into a lightly trade stock and Bam down she went. Two more FDA trials remain company has 36million in cash. Chart set up is the best a bounce into the gap is coming very soon the stock is basing and moving higher today. Use this week to accumulate. Expect news updating shareholders next week. This could easily run back to $4-7 a share.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p78879038318
ALIM $1.26 only 7 mil float $1.25 cash per share. Intraday Gap from $6.33- $2.55. Nov 11 FDA rejected 2nd trial someone dump on a market order into a lightly trade stock and Bam down she went. Two more FDA trials remain company has 36million in cash. Chart set up is the best a bounce into the gap is coming very soon the stock is basing and moving higher today. Use this week to accumulate. Expect news updating shareholders next week. This could easily run back to $4-7 a share.
http://stockcharts.com/h-sc/ui?s=ALIM&p=D&b=5&g=0&id=p78879038318
MFGLQ .24 Huge gap from .33-$1.2 bounce over next few days
MFGLQ .24 Huge gap from .33-$1.2 bounce over next few days